NL-OMON30361已完成不适用
QTc-prolongation due to combinations of drugs - a prospective study with a focus on pharmacokinetic and pharmacogenetic risk factors - QTc-prolongation due to combinations of drugs
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •All patients for whom a combination of 2 or more QTc-interval prolonging drugs have been prescribed.
排除标准
- •No written informed consent obtained.
- •Patients in whom life expectancy or clinical situation is such that a risk of heart rhythm disturbances is irrelevant to clinical care.
研究者
相似试验
尚未招募
不适用
The effect of chemotherapy-induced QT prolongation on all-cause mortality in cancer patients-a retrospective observational cohort studyDiseases of the circulatory systemKCT0006836ational Cancer Center13,032
已完成
4 期
QTc-prolongation in the use of antidepressants for anxiety-disordersLong QT syndromeNL-OMON38604Parnassia (Den Haag)60
已完成
不适用
Drug-Drug interaction study in HVNL-OMON28697Denali Therapeutics, Inc16
已完成
1 期
Pharmacokinetics and Safety of Rivastigmine Nasal Spray versus Exelon (Registered Trademark) Capsule in Healthy MeAlzheimer's diseaseNeurological - Alzheimer's diseaseACTRN12619001513101achesis Biosciences Ltd16
已完成
1 期
Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy SubjectsDrug-induced Surface ECG ChangesNCT01873950Food and Drug Administration (FDA)22